਀㰀栀琀洀氀㸀 ਀㰀氀椀渀欀 爀攀氀㴀∀猀琀礀氀攀猀栀攀攀琀∀ 琀礀瀀攀㴀∀琀攀砀琀⼀挀猀猀∀ 栀爀攀昀㴀∀猀琀礀氀攀⸀挀猀猀∀⼀㸀 ਀㰀戀漀搀礀㸀

Centre de Référence des Rhumatismes Inflammatoires et Maladies Autoimmunes Systémiques Rares de l’Enfant (RAISE) / 2017

68

P,

et

al.

methotrexate

Leflunomide

or

juvenile

for

rheumatoid

arthritis.

N

Engl

J

Med.

2005

21;352(16):1655–66.

Apr

Silverman E, Spiegel L, Hawkins

D,

Petty

R,

Goldsmith

D,

Schanberg

L,

et

al.

Long-term

open-label

preliminary

study

of

the

safety

leflunomide

and

efficacy

of

in

patients

with

polyarticular-course

juvenile
Arthritis

rheumatoid

arthritis.

Rheum.

2005

Feb;52(2):554–

62.

Van

Rossum

MAJ,

Boers

van

M,

Soesbergen

RM,

Zwinderman

AH,

Fiselier

TJW,

Franssen

MJAM,

et

al.

Long-

term

outcome

of

juvenile

idiopathic

arthritis

following

a

trial:

early

Ann

2007

placebo-controlled

sustained

benefits

of

treatment.

Dis.

sulfasalazine
Rheum
Nov;66(11):1518–24.

Verbsky JW, White AJ. Effective

use

of

the

recombinant

interleukin 1 receptor antagonist

anakinra
systemic

in

therapy

resistant

onset

juvenile

rheumatoid
Rheumatol.

arthritis.

J

2004

Oct;31(10):2071–5.

Vojvodich
Andersson
Hagelberg

PF,

U,

Hansen

Sävendahl

JB,

L,

Etanercept

S.

treatment

improves

longitudinal

growth

in

prepubertal

children

with

juvenile

idiopathic

arthritis.

J

Rheumatol.

Dec;34(12):2481–5.

2007

Woo P, Wilkinson N, Prieur A-M,

Southwood

T,

Leone

V,

Livermore

P,

label

et

al.

Open

trial

phase

II

of

single,

ascending

doses

of

MRA

in

Caucasian

children

with

juvenile

severe

systemic

idiopathic

arthritis:

proof

of

principle of the efficacy of IL-
6

receptor

blockade

in

this

type

of

arthritis

and

demonstration

of

prolonged

clinical improvement. Arthritis
Res

Ther.

2005;7(6):R1281-

1288.

Wulffraat

NM,

Brinkman

D,

Ferster

A,

Opperman

J,

ten

Cate R, Wedderburn L, et al.

Long-term
autologous

follow-up

stem

of

cell

transplantation

for

refractory

juvenile

idiopathic

arthritis.

Transplant.

Bone

Marrow

2003 Aug;32 Suppl 1:S61-64.

Yokota

S,

Imagawa

T,

Mori

M,

Miyamae

T,

Aihara

Y,

Takei

S,

et

al.

Efficacy

and

safety

of

tocilizumab

in

patients

with

systemic-onset

juvenile

idiopathic

arthritis:

a

randomised,

double-blind,

placebo-controlled,

withdrawal
Lancet.

phase

2008

III

trial.

Mar

22;371(9617):998–1006.

Yokota
Imagawa

S,

T,

Miyamae

Iwata

T,

N,

Katakura

S,

Mori

M,

et

al.

Therapeutic

efficacy

of

humanized

recombinant

anti-

interleukin-6

receptor

antibody

in

children

with

juvenile

systemic-onset
idiopathic

arthritis.

Arthritis

Rheum. 2005 Mar;52(3):818–
25.

਀㰀⼀栀琀洀氀㸀